De novo production of genetically engineered T cells is maintained in humans decades after loss of transplanted hematopoietic stem cellsN. Izotova,C. Rivat,C. Baricordi,D. Pellin,S. Adams,A. S. Gkazi, E. Watt,A. J. Thrasher,L. BiascoHUMAN GENE THERAPY(2019)引用 0|浏览20暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要